CVS Health stock is trading -32.94% below its average target price of $66.26 after dropping -1.1% during today's afternoon session. Analysts are giving the Large-Cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $48.01 to $93.0 per share.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.4%. The stock's short ratio is 1.45. The company's insiders own 0.13% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 82.8%. In conclusion, we believe there is positive market sentiment regarding CVS Health.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-09-30 | Vanguard Group Inc | 9% | 117,616,432 | $5,226,286,317 |
| 2024-09-30 | Blackrock Inc. | 8% | 104,549,511 | $4,645,657,664 |
| 2024-09-30 | Dodge & Cox Inc | 5% | 63,030,690 | $2,800,768,796 |
| 2024-09-30 | State Street Corporation | 4% | 56,527,909 | $2,511,817,714 |
| 2024-09-30 | Capital World Investors | 4% | 48,220,629 | $2,142,683,715 |
| 2024-09-30 | FMR, LLC | 2% | 28,327,041 | $1,258,712,105 |
| 2024-09-30 | Geode Capital Management, LLC | 2% | 26,361,673 | $1,171,380,975 |
| 2024-09-30 | Capital International Investors | 2% | 25,454,275 | $1,131,060,744 |
| 2024-09-30 | Morgan Stanley | 2% | 22,248,342 | $988,605,107 |
| 2024-06-30 | Norges Bank Investment Management | 1% | 14,901,126 | $662,131,554 |
